At OhmBody, there is an in-house clinical team, and an in-house RMD team “that will continue to do research and run down the pathway around endometriosis, PCOS, postpartum hemorrhaging, adolescent HMB, the list for bleeding is just so long,” Gaston shared. That’s why “we want FDA approval for indications in those spaces.”